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Abstract N-Ethylmaleimide-sensitive factor (NSF) is required
for multiple pathways of vesicle-mediated protein transport.
Microinjection of a monoclonal anti-NSF antibody almost
completely blocked brefeldin A-promoted Golgi disassembly
without affecting the rapid release of L-COP, a subunit of the
Golgi coat proteins (COPI), from the Golgi apparatus. Similar
results were obtained using a dominant-negative NSF which is
known to compete with endogenous NSF. The present results
suggest that an NSF-mediated step is present in the brefeldin
A-promoted disassembly of the Golgi apparatus.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The transport of proteins between compartments of the
biosynthetic and endocytic pathways is mediated by vesicles
that bud from the donor compartment and move to the target
compartment, where the fusion of vesicles occurs. N-Ethyl-
maleimide-sensitive factor (NSF) is a key component for the
fusion of transport vesicles [1^4]. Studies involving cell-free or
permeabilized cell systems revealed that NSF is involved in
many transport pathways [1] and in the formation of Golgi
stacks from Golgi-derived vesicles [5,6].
NSF is associated with membranes as a 20S complex of
proteins including soluble NSF attachment proteins (SNAPs)
[7] and SNAP receptors (SNAREs) [8]. Disassembly of the
20S complex in vitro is probably evoked by the hydrolysis
of Mg2-ATP by NSF, and thereby NSF and SNAPs are
released from membranes [8,9]. Although it was proposed
that the disassembly of the 20S complex triggers the fusion
of the vesicles which have been docked with the target mem-
brane [1], recent studies rather suggest that NSF has a pre-
docking role [3,4].
Brefeldin A (BFA) induces remarkable morphological
changes of organelles [10]. This compound promotes the rapid
release of Golgi-coat proteins, COPI [11], and thereby causes
Golgi components to be redistributed into the endoplasmic
reticulum (ER) [12^14]. It also promotes the extensive tubu-
lation of endosomes [15^17]. BFA inhibits the exchange of
guanine nucleotide bound to ADP-ribosylation factor (ARF)
[18,19]. Since the GTP-dependent interaction of ADP-ribosy-
lation factor with Golgi membranes is required for the asso-
ciation of COPI with the membranes [20,21], inhibition of the
exchange of guanine nucleotide onto ARF causes the release
of COPI from the Golgi apparatus [11], which promotes the
redistribution of Golgi components into the ER. However,
dissociation of COPI from Golgi membranes is not su⁄cient
for the disassembly of the Golgi apparatus. Calmodulin an-
tagonists block BFA-promoted Golgi disassembly without af-
fecting the rapid release of COPI [22]. It was recently shown
that ADP-ribosylation [23] and protein prenylation [24] are
required for BFA-promoted retrograde transport. Although
the use of BFA has provided valuable information regarding
the control of organelle structures as well as membrane tra⁄c
[10], the mechanism of the disassembly of the Golgi apparatus
and the tubulation of endosomes is not fully understood.
To examine the involvement of NSF in BFA-promoted
Golgi disruption, we used a microinjection method. Micro-
injection of antibodies into cells is a powerful method to study
intracellular transport in vivo. In this paper we showed that
mAb 2C8 and a dominant-negative NSF protein, both of
which are known to inhibit endogenous NSF [25,26], block
the disassembly of the Golgi apparatus induced by BFA.
2. Materials and methods
2.1. Materials
CELLocate 5245 (square size, 175 mm) was obtained from Eppen-
dorf (Hamburg, Germany). BFA was purchased from Wako Chem-
icals (Osaka, Japan). IgG of mAb 2C8 was prepared as previously
described [25]. Polyclonal antibodies against mannosidase II (man II)
and L-COP were kindly donated by Drs. K. Moremen (University of
Georgia) and Y. Ikehara (Fukuoka University), respectively.
NSF(K266Q) and NSF(K549Q) in which Lys-266 and Lys-549 were
individually replaced by glutamine were isolated as described [26].
2.2. Cell culture
Chinese hamster ovary (CHO) cells donated by Dr. H. Tanaka of
this university, and normal rat kidney (NRK) cells obtained from the
Riken Cell Bank (Wako, Japan) were grown in minimum essential
medium (K-MEM) supplemented with 50 IU/ml penicillin, 50 Wg/ml
streptomycin and 7.5V10% fetal calf serum under a humidi¢ed at-
mosphere of 95% air and 5% CO2.
2.3. Immuno£uorescence and electron microscopic analyses
Immuno£uorescence analysis was performed as previously de-
scribed [27]. Brie£y, cells were ¢xed with 4% paraformaldehyde in
phosphate-bu¡ered saline containing 0.25 M sucrose, permeabilized
with 0.2% Triton X-100, and then blocked with 2% bovine serum
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albumin. Next, the cells were incubated with the primary and then the
secondary antibodies.
For electron microscopic analysis, the cells were ¢xed in 2.5% glu-
taraldehyde in 0.1 M phosphate bu¡er (pH 7.4) at 4‡C overnight, and
then post-¢xed in 1% OsO4 in 0.1 M cacodylate bu¡er for 1 h. After
washing, they were dehydrated in 50% ethanol for 10 min, and then
block-stained with 2% uranyl acetate in 70% ethanol for 2 h. The cells
were further dehydrated with a graded series of ethanol, and then
embedded in epoxy resin. Ultrathin sections were doubly stained
with uranyl acetate and lead citrate, and then observed under a Hi-
tachi H7000 electron microscope.
2.4. Microinjection
Antibodies or NSF mutants were centrifuged, and then ¢ltered
through Micropure (Amicon, Beverly, MA, USA) before use. To
identify injected cells, CELLocate was used as coverslips. The medium
for cells contained 25 mM HEPES (pH 7.2) during microinjection.
Microinjection was performed using an Eppendorf Microinjector 5242
with Femtotips (Eppendorf, Hamburg, Germany) with an injection
time of 0.2 s and 0.6 s for antibodies and NSF mutants, respectively.
At least more than 40 cells were injected.
3. Results
3.1. mAb 2C8 inhibits BFA-promoted Golgi disassembly
We ¢rst examined whether mAb 2C8 speci¢cally recognizes
NSF from CHO cells. Immunoprecipitation and immuno-
£uorescence analyses revealed that the antibody speci¢cally
recognizes NSF from CHO cells (data not shown). To exam-
ine the involvement of NSF in the disassembly of the Golgi
apparatus promoted by BFA, mAb 2C8 at a concentration of
4.0 mg/ml was injected into CHO cells, and then the cells were
incubated with 10 WM BFA for 40 min. Fig. 1B,C show cells
double-immunostained with antibodies against man II and
mouse IgG (i.e. injected antibody), respectively. In injected
cells (indicated by arrows), signi¢cant immunoreactivity for
man II was still detected in the perinuclear region, although
its shape became round. On the other hand, immunoreactivity
for man II was dispersed throughout the cytoplasm in non-
injected cells, re£ecting the redistribution of man II into the
ER. When the concentration of mAb 2C8 for injection was
lower than 1.0 mg/ml, its e¡ect was not remarkable. However,
Golgi disassembly was blocked in almost all cells (at least 40
cells examined) when 4.0 mg/ml mAb 2C8 was injected. Elec-
tron microscopic analysis revealed that the Golgi apparatus
consisting of several stacks is indeed present in mAb 2C8-
injected cells in spite of incubation with BFA (Fig. 2).
Since NSF from NRK cells was not recognized by mAb
2C8, this cell line is suitable for evaluating the speci¢city of
the inhibitory e¡ect of mAb 2C8. When mAb 2C8 was in-
jected, and then the cells were incubated with BFA, redistri-
bution of man II into the ER occurred in injected cells as well
as non-injected cells (data not shown), suggesting that the
inhibitory e¡ect of mAb 2C8 is speci¢c.
One possibility to explain the blockage of BFA-promoted
Golgi disassembly by mAb 2C8 in CHO cells is that the anti-
body suppressed the rapid release of COPI from Golgi mem-
branes. However, this possibility was excluded by the ¢nding
that the release of L-COP, a subunit of COPI [28,29], from the
Golgi apparatus occurred within 3 min in both injected (the
cell indicated by an arrow in Fig. 1E) and non-injected cells.
These results suggest that NSF is not involved in the binding
of L-COP to the Golgi apparatus, but is required for BFA-
promoted Golgi disassembly [30].
3.2. A dominant-negative NSF inhibits BFA-promoted Golgi
disassembly
To con¢rm that NSF activity is required for BFA-pro-
moted Golgi disassembly, we used a dominant-negative
NSF. NSF contains the amino-terminal and two homologous
nucleotide-binding domains [31] whose connecting regions
are susceptible to proteolysis [25]. We previously constructed
mutant NSF proteins in which Lys-266 and Lys-549 in
the consensus sequences for nucleotide binding are individu-
ally replaced by glutamine, referred to as NSF(K266Q)
and NSF(K549Q), respectively. NSF(K266Q) but not
NSF(K549Q) inhibits an intra-Golgi transport assay [26].
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Fig. 1. mAb 2C8 inhibits BFA-induced disassembly of the Golgi apparatus without a¡ecting the rapid release of L-COP in CHO cells. Immedi-
ately after injection of intact mAb 2C8 into CHO cells, the cells were incubated with 10 WM BFA for 40 min (B and C) or 3 min (E and F).
Double-staining for man II (B) and the injected antibody (C), and double-staining for L-COP (E) and the injected antibody (F). Staining for
man II (A) and L-COP (D) in untreated cells is shown. Arrows indicate injected cells.
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Whiteheart and colleagues [32,33] also showed that the NSF
mutant in which Lys-266 is replaced by alanine has a similar
e¡ect.
NRK cells were chosen for the microinjection of NSF mu-
tants because these cells express lower amounts of NSF than
CHO cells (data not shown). To localize injected cells, mouse
IgG was co-injected with NSF(K266Q). The injected cells
were incubated with 10 WM BFA for 40 min, and then dou-
ble-immunostained with antibodies against man II (Fig. 3B)
and mouse IgG (Fig. 3C). In injected cells man II was not
redistributed and still located in the perinuclear region, where-
as it was redistributed into the ER in non-injected cells. We
examined about 40 injected cells, and found that Golgi dis-
assembly was prevented in almost all cells when the mutant at
a concentration of 1.5 mg/ml or higher was injected. As in the
case of microinjection of mAb 2C8 into CHO cells, the BFA-
promoted release of L-COP from the Golgi apparatus oc-
curred rapidly in both injected and non-injected NRK cells,
although L-COP was not completely released by BFA in the
case of this cell line (Fig. 3G,H). When NSF(K549Q), a mu-
tant that does not compete with endogenous NSF [26], was
used, the disassembly of the Golgi apparatus was caused by
BFA in both injected and non-injected cells (Fig. 3D,E), re-
£ecting the speci¢city of the inhibitory e¡ect of NSF(K266Q).
4. Discussion
BFA promotes the Golgi apparatus to be disassembled into
tubular structures. The tubules containing most Golgi compo-
nents move to the ER, and then fuse with the membrane [12^
14]. In the present study, we investigated the role of NSF in
the action of BFA using a microinjection method. Disassem-
bly of the Golgi apparatus was remarkably blocked when
CHO cells were microinjected with mAb 2C8, although
L-COP was rapidly released from the Golgi apparatus. Similar
results were obtained with NSF(K266Q), a mutant NSF
which inhibits an intra-Golgi transport assay by competing
with endogenous NSF. In control experiments microinjection
of mAb 2C8 or NSF(K549Q) into NRK cells did not inhibit
the redistribution of man II into the ER. These results
strongly suggest that NSF is required for BFA-promoted Gol-
gi disassembly. This idea is consistent with the recent ¢nding
that N-ethylmaleimide blocks the movement of Golgi tubules
induced by BFA and prevents the redistribution of Golgi
components into the ER [34].
The Golgi apparatus is a highly dynamic organelle, in
which the formation and/or detachment of tubules constantly
occur among adjacent Golgi membranes [34,35]. In spite of
this dynamics, the overall Golgi structure is fairly maintained
during interphase. However, when coat proteins are removed
by BFA, the organelle is redistributed into the ER via a ten-
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Fig. 3. Disassembly of the Golgi apparatus is inhibited by NSF(K266Q), but not by NSF(K549Q). Immediately after injection of NSF(K266Q)
(B, C, G, and H) or NSF(K549Q) (D and E), the cells were incubated with 10 WM BFA for 40 min (B^E) or 3 min (G and H). To localize
the injected cells, a control mouse IgG was co-injected with an NSF mutant. Double-staining for man II (B and D) and the injected antibody
(C and E), and double-staining for L-COP (G) and the injected antibody (H). Staining for man II (A) and L-COP (F) in untreated cells is
shown. Arrows indicate injected cells.
Fig. 2. The Golgi apparatus in CHO cells is not disassembled by
BFA in cells injected with mAb 2C8. Immediately after injection of
mAb 2C8 into CHO cells, the cells were incubated with 10 WM
BFA for 40 min, ¢xed with glutaraldehyde, and then processed for
electron microscopic analysis. The arrow indicate the position of the
Golgi apparatus. Bar = 200 nm.
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sion-driven membrane £ow mechanism [34]. On the other
hand, when the release of coat proteins is blocked by an anti-
body against L-COP, the Golgi apparatus is disassembled by
BFA, but its components are not returned into the ER [36].
These ¢ndings may suggest that coat proteins blocks non-spe-
ci¢c fusion by covering the fusion machinery such as the NSF-
SNAP-SNARE complex. This idea is supported by the fact
that isolated Golgi membranes are fused to form extensive
tubular networks in a cytosol-, ATP- and NSF-dependent
manner, when coat proteins are removed by BFA in vitro
[37]. The present results are most likely relevant to these in
vitro observations.
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